Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia.

Platzbecker U, Sockel K, Schönefeldt C, Nowak D, Helas S, Röllig C, Mossner M, Jann JC, Ehninger G, Hofmann WK, Bornhäuser M, Thiede C, Wermke M.

Haematologica. 2014 Dec;99(12):e247-8. doi: 10.3324/haematol.2014.111948. Epub 2014 Sep 5. No abstract available.

2.

Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation.

Schönefeldt C, Sockel K, Wehner R, Sopper S, Wolf D, Wermke M, Thiede C, Oelschlägel U, Ehninger G, Bornhäuser M, Platzbecker U, Schmitz M.

Blood Cancer J. 2013 Aug 30;3:e136. doi: 10.1038/bcj.2013.35. No abstract available.

3.

Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.

Ferrer RA, Wobus M, List C, Wehner R, Schönefeldt C, Brocard B, Mohr B, Rauner M, Schmitz M, Stiehler M, Ehninger G, Hofbauer LC, Bornhäuser M, Platzbecker U.

Haematologica. 2013 Nov;98(11):1677-85. doi: 10.3324/haematol.2013.083972. Epub 2013 May 28.

4.

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study.

Platzbecker U, Braulke F, Kündgen A, Götze K, Bug G, Schönefeldt C, Shirneshan K, Röllig C, Bornhäuser M, Naumann R, Neesen J, Giagounidis A, Hofmann WK, Ehninger G, Germing U, Haase D, Wermke M.

Leukemia. 2013 Jun;27(6):1403-7. doi: 10.1038/leu.2013.26. Epub 2013 Jan 28. No abstract available.

5.

Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.

Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, Thiede C, Schönefeldt C, Lehnert R, Eisenhofer G, Siegert G.

BMC Cancer. 2012 Dec 5;12:576. doi: 10.1186/1471-2407-12-576.

6.

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.

Wermke M, Schmidt A, Middeke JM, Sockel K, von Bonin M, Schönefeldt C, Mair S, Plodeck V, Laniado M, Weiss G, Schetelig J, Ehninger G, Theurl I, Bornhäuser M, Platzbecker U.

Clin Cancer Res. 2012 Dec 1;18(23):6460-8. doi: 10.1158/1078-0432.CCR-12-1683. Epub 2012 Sep 18.

7.

Local expression of insulin-like growth factor (IGF) signaling components during in vitro aging of mesenchymal stem cells.

Schilling T, Schonefeldt C, Zeck S, Meissner-Weigl J, Schneider D, Jakob F, Ebert R.

J Stem Cells Regen Med. 2007 May 16;2(1):41-2. eCollection 2007. No abstract available.

PMID:
24692894
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk